I’ve heard a lot of venture capitalists say they’re looking for the next Mark Zuckerberg, but when Henry McCance used that phrase in relation to finding a cure for Alzheimer’s disease, it didn’t sound as far-fetched as usual.
Henry McCance is no ordinary venture capitalist. As longtime chairman and president of Greylock Partners, one of the oldest and most revered VC firms, McCance has helped find plenty of Mark Zuckerbergs in more than four decades at the firm. In fact, he even helped locate the real one in 2006, when Greylock invested $12.5 million in Facebook. That investment netted the firm a $1.5 billion profit last year.
McCance was talking to me from the office of Dr. Rudy Tanzi, a researcher at Massachusetts General Hospital, about his approach to finding a cure for Alzheimer’s disease. Through the Wellesley, Mass.-based foundation he co-founded in 2005, the Cure Alzheimer’s Fund, McCance aims to take a venture capital approach to the disease. That involves funding bold but risky research, eliminating red tape, and providing for communication among researchers. But for a more complete explanation of what that means, McCance agreed to talk for a short video.
In Friday’s issue of the Boston Business Journal, I talk about the advances the non-profit organization has made and where it’s headed (for paid subscribers only).
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEtmrNxLb5Lg5XsKme39zlELfBAuw&url=http://www.bizjournals.com/boston/blog/bioflash/2013/05/ninety-seconds-with-henry-mccance-on.html
0 comments:
Post a Comment